Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: A Gynecologic Oncology Group study
David Cella*, Helen Q. Huang, Bradley J. Monk, Lari Wenzel, Jo Benda, D. Scott McMeekin, David Cohn, Lois Ramondetta, Cecelia H. Boardman
Fingerprint
Dive into the research topics of 'Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: A Gynecologic Oncology Group study'. Together they form a unique fingerprint.